Clinical Trial Update: Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 Romance pilot trial evaluating rosiglitazone in combination with metformin in nondiabetic patients with stable coronary syndromes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED